Red Wine Protects The Prostate – Harvard Men’s Health Watch
Researchers have found that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine, reports the June 2007 issue of Harvard Men’s Health Watch. In addition, red wine appears particularly protective against advanced or aggressive cancers.
Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption. At first the results for alcohol consumption seemed similar to the findings of many earlier studies: There was no relationship between overall consumption and risk.
But the scientists went one step further by evaluating each type of alcoholic beverage independently. Here the news was surprising—wine drinking was linked to a reduced risk of prostate cancer. And when white wine was compared with red, red had the most benefit. Even low amounts seemed to help, and for every additional glass of red wine per week, the relative risk declined by 6%.
Why red wine? Doctors don’t know. But much of the speculation focuses on chemicals—including various flavonoids and resveratrol—missing from other alcoholic beverages. These components have antioxidant properties, and some appear to counterbalance androgens, the male hormones that stimulate the prostate.
Many doctors are reluctant to recommend drinking alcohol for health, fearing that their patients might assume that if a little alcohol is good, a lot might be better. The Harvard Men’s Health Watch notes that men who enjoy alcohol and can drink in moderation and responsibly may benefit from a lower risk of heart attack, stroke, diabetes, and cardiac death.
October 22, 2007 at 11:43 am
My friends father died of Asbestos related illness and cancer. I inspired me to delve into the available research and information on how these terrible events might be avoided or life extended.
From what i have read of the published medical data and research, particularly that conducted in China and Japan there is a great deal of evidence to support complimentary immune therapy, especially with infections and cancer. I’ve been following with some interest the development of a complimentary cancer treatment that has been designed in liason with the University of Newcastle (Australia) and although a somewhat different approach to the above outlined treatment the concept and the deliberate and effective use of natural elements in the product are similar. If you have an interest in this field or perhaps just want to keep abreast of a new treatment you may find http://www.mc-s.com.au fairly worthwhile reviewing.